OptiCross Coronary Imaging Catheter (H749518110) +7 more— 510(k) K260816

Substantially Equivalent

Boston Scientific

FDA 510(k) clearance K260816 for OptiCross Coronary Imaging Catheter (H749518110) +7 more, Substantially Equivalent on 2026-04-08. Applicant: Boston Scientific. Device class: 2.

Summary

Boston Scientific's record names eight OptiCross Coronary Imaging Catheter entries: the OptiCross, OptiCross 6, OptiCross HD, and OptiCross 6 HD, each also listed in a Bagless version, with a separate number for each. All are filed under product code OBJ (Catheter, Ultrasound, Intravascular).

Class II, 21 CFR 870.1200. It came in as a Special 510(k), and Cardiovascular is both the classification panel and the review panel.

Boston Scientific filed from Maple Grove, Minnesota. Review took 26 calendar days (March 13 to April 8, 2026).

Clearance details

Device name as filed
OptiCross Coronary Imaging Catheter (H749518110); OptiCross 6 Coronary Imaging Catheter (H7495181160); OptiCross HD Coronary Imaging Catheter (H74939352040); OptiCross 6 HD Coronary Imaging Catheter (H74939354080); OptiCross Coronary Imaging Catheter (Bagless) (H749518130); OptiCross 6 Coronary Imaging Catheter (Bagless) (H7495181360); OptiCross HD Coronary Imaging Catheter (Bagless) (H74939352050); OptiCross 6 HD Coronary Imaging Catheter (Bagless) (H74939354090)
Applicant
Boston Scientific
Product code
Product code OBJ
Device class
Class 2
Regulation
21 CFR 870.1200
Advisory panel
Cardiovascular
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Maple Grove, MN, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code OBJ

view all

More clearances from Boston Scientific

view all

Adverse events under product code OBJ

product code OBJ
Death
38
Injury
634
Malfunction
3,453
Total
4,125

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.